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Tobacco mosaic tobamovirus (TMV) coat protein (CP) mutant E50Q lacks a repulsive intersubunit carboxylate group and
can effectively inhibit the disassembly of wild-type TMV (Culver et al., 1995, Virology 206,724). To investigate the ability of this
mutant CP to block disassembly, a series of second-site amino acid substitutions were added to the E50Q CP. These
second-site mutations were designed to disrupt specific intersubunit stabilizing interactions involving hydrophobic or polar
residues, salt bridges, and CP–RNA contacts. Results showed substitutions disrupting intersubunit interactions that face the
disassembling surface of the virion dramatically reduced the ability of CP E50Q to inhibit TMV disassembly. Substitutions that
disrupted the CP inner loop, RNA binding capabilities, or intersubunit interactions that faced away from the disassembling
surface did not dramatically interfere with CP E50Q’s ability to inhibit disassembly. Taken together, these findings suggest
that intersubunit interactions made by 59 terminal E50Q subunits, not associated with RNA, provide the stabilizing forces that
prevent virion disassembly. The role of these stabilizing interactions in TMV disassembly and their potential use for creating
disassembly inhibiting CPs are discussed. © 1998 Academic Press
Virus particles alter their stability in response to
changing environmental conditions. This feature protects
the virus genome from degradation while insuring its
release upon entry into a host cell. Crystallographic
studies of several plant RNA viruses have indicated a
range of intersubunit protein–protein or protein–nucleic
acid interactions that potentially contribute to virion sta-
bility and/or instability (1). One such interaction involves
the clustering of intersubunit carboxylate groups whose
electrostatic repulsion could destabilize subunit to sub-
unit interactions (1–3). Under conditions favoring virion
stability these repulsive interactions could be neutralized
by protons or calcium ions. However, changes in pH and
calcium concentrations associated with host cell entry
may displace the stabilizing protons and calcium ions,
allowing the repulsive carboxylate groups to interact and
thus initiate disassembly. In this fashion, carboxylate
interactions could provide a sensitive switching mecha-
nism for controlling virion stability.
The involvement of carboxylate groups in the disas-
sembly of tobacco mosaic tobamovirus (TMV) has been
investigated (4, 5). The TMV virion is a rigid rod com-
posed of approximately 2130 identical 17.5-kDa coat pro-
tein (CP) subunits assembled to form a right-handed
helix around a single strand of plus-sense RNA (1, 6; Fig.
1). The structure of TMV at 2.9 Å resolution reveals three
intersubunit carboxylate interactions: one axially be-
tween residues E50 and D77, one laterally between res-
idues E106 and E95, and one between residue D116 and
an RNA phosphate group (7). All three charge pairs are
thought to contribute to the anomalous titration behavior
of TMV, with the E95/E106 and D116/phosphate pairs
acting as calcium binding sites (7). Site-directed mu-
tagenesis was used to change these negatively charged
E or D residues to neutral amide Q or N residues,
respectively (4, 5). These substitutions alter only the
repulsive charge and do not affect hydrogen bonding or
hydrophobic interactions. The effects of amide mutations
on TMV disassembly were determined by measuring the
ability of purified mutant CPs to inhibit the disassembly
of wild-type TMV virions in both plant infectivity and in
vitro cotranslational assays. Results showed that wild-
type TMV virions partially reconstituted with specific
amide mutant CPs, such as CP E50Q, were significantly
inhibited in cotranslational activity and infectivity. These
findings demonstrated the importance of repulsive inter-
subunit interactions in driving disassembly.
In contrast to repulsive carboxylate interactions, the
majority of TMV CP–CP interactions act to stabilize the
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virion. These stabilizing interactions include patches of
hydrophobic and polar residues, intersubunit salt
bridges, and CP–RNA interactions (7). The ability of
amide mutant CPs lacking repulsive carboxylate groups
to inhibit TMV disassembly is likely the result of en-
hanced virion stability due to some or all of these stabi-
lizing interactions. Understanding how these interactions
stabilize the virion and prevent disassembly should ex-
pand our understanding of the disassembly process and
may reveal novel approaches for the rationale design of
additional CP mutants that inhibit virus disassembly.
To identify the molecular interactions that allow car-
boxylate CP mutants to inhibit TMV disassembly, a series
of mutations designed to disrupt specific CP stabilizing
features were added to the existing carboxylate mutant
CP E50Q. Site-directed mutagenesis (5, 8) and in vitro
transcriptions (9, 10) were performed as previously de-
scribed. Infectious RNA transcripts for each new double
mutant were mechanically inoculated onto leaves of
Nicotiana tabacum cv. Xanthi. Twenty days after infec-
tion, virus particles were purified as described (11), using
differential centrifugation steps or fractionation in a 10–
40% sucrose gradient. The maintenance of each created
CP mutation was confirmed by the sequencing of reverse
transcription and polymerase chain reaction-amplified
cDNA products obtained from viral RNA isolated from
infected plant tissue (12). Coat protein from each double
mutant was purified from isolated virus particles via
acidic acid degradation (13) and concentrations were
determined by Bradford assay (14). Polyacrylamide gel
electrophoresis (15) was also used to compare CP con-
centrations and to insure the purity of each preparation.
All E50Q second-site CP mutants assembled into viri-
on-like helical rods of various lengths in planta (Table 1).
Purified rods displayed OD260/280 ratios that were similar
to the parent mutant E50Q, but lower than wild-type TMV
(Table 1). This indicated that the double mutant rods, like
their E50Q parent, contained less than wild-type levels of
RNA. The E50Q mutation is known to increase the sta-
bility of the protein helix, resulting in the formation of
greater than wild-type length helical rods (5; Table 1).
This stabilization results in fewer of the 20S CP aggre-
gates required for RNA assembly and, therefore, fewer
virions (16). The ability to form virion-like rods indicates
TABLE 1
Characterization of E50Q Double Mutants
Coat protein
substitutions
combined with E50Q Position
Rod lengtha
(nm) OD260/OD280
F10Y N terminus 151 6 23 1.02
T281 LS helix 106 6 41 0.87
T42R RS helix 168 6 52 1.06
F67A b sheet 318 6 159 0.90
D88N RR helix 476 6 126 0.82
R90Q/R92E Long loop 336 6 140 0.83
P102L Long loop 213 6 93 1.06
D116A LR helix 484 6 190 0.84
I129A LR helix 265 6 185 1.14
I133L LR helix 131 6 80 0.99
Wild-type NA 300 6 20 1.18
E50Q RS helix 1042 6 246 0.87
a Rod lengths are the average length 6 standard deviation of 40–60
rods measured from electron micrographs of virus particles purified
from infected N. tabacum tissues.
FIG. 1. Computer graphic representations of the 59 end of the TMV
virion and single coat protein subunit. (A) Virion 59 end showing the
disassembly surface viewed from the top, perpendicular to the viral
axis, or from the side, parallel to the viral axis. (B) Ribbon representa-
tion of the a carbon backbone of a single TMV coat protein subunit. The
four a-helices are labeled LS (left slewed), RS (right slewed), LR (left
radial), and RR (right radial). The inner loop connects the LR and RR
helices and a short loop connects LS and RS helices. The RNA binding
site is formed by residues from both loops and the LR helix. The N- and
C-termini are at the outer radius of the virus.
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that these mutant CPs maintained their overall three-
dimensional structures and were competent to self as-
sociate. However, the virion-like rods produced by the
double mutants were significantly shorter then those
produced by the parent E50Q mutant (Table 1). The
presence of shorter rods suggests that each of the sec-
ond-site substitutions interfered enough with the self-
association of CP E50Q to disrupt its ability to form long
helical rods.
RNA empty rods of differing lengths preclude the use
of disassembly assays based on quantifying the expo-
sure of RNA or measuring changes in virion length. To
circumvent these problems, an assay measuring the
ability of purified mutant CPs to inhibit the disassembly
of wild-type TMV virions was used (5). This assay takes
advantage of the fact that under the appropriate buffer
conditions TMV disassembly initiates from the RNA 59
end and is a partially reversible process (17–20). For this
procedure, purified wild-type TMV virions (0.4 mg) were
incubated for 15 min under mild alkaline conditions (0.01
M Tris–HCl, pH 8.0) that favor the removal of a few CP
subunits from the RNA 59 end (18, 19). However, TMV
virions treated in this fashion remain resistant to micro-
coccal nuclease treatment (18), indicating that the viral
RNA is not sufficiently exposed to allow degradation.
Alkaline-buffered virions were subsequently treated by
the addition of an equal volume of 0.1 M Tris–HCl, pH 7.4
buffer containing excess purified mutant CPs (4.0 mg)
and incubated for an additional 30 min. These conditions
favor virion reconstitution (17) and presumably allow the
mutant CPs to bind to the exposed surface of the virion
59 end. The partially reassembled virions were pelleted
by centrifugation (65,000 rpm in a Beckman TLA100.3
rotor for 10 min at 4°C) to remove any unassociated CP.
Virions reconstituted in this manner were then used to
inoculate a TMV local lesion host (N. tabacum cv. Xan-
thi-nc) to test for effects on infectivity or assayed in a
rabbit reticulocyte system for effects on cotranslational
activity. Comparisons in the infectivity (numbers of local
lesions) and cotranslational abilities (levels of viral 126-
kDa protein) of TMV virions partially reassembled with
either excess wild-type, E50Q, or E50Q double mutant
CPs were used as measures of the ability of second-site
substitutions to interfere with E50Q’s inhibition of TMV
disassembly. Results from both assays were well corre-
lated, indicating that the observed effects occurred both
in vitro and in vivo (Fig. 2).
Intersubunit hydrophobic interactions play an impor-
tant role in stabilizing the TMV virion (7). At the outer
radius of the virion residues P20 and F67 from one
FIG. 2. Infectivity and translational inhibition of wild-type TMV virions treated with a 10,000 fold excesses of mutant or wild-type CP. Infectivity assays
were conducted by inoculating one half of each leaf with 0.2 mg of wild-type virions partially reassembled with excess wild-type or mutant CPs, while
the other half-leaf received identically treated wild-type virions except with the omission of added extra CP. Numbers of local lesions appearing on
each half leaf were used to calculate the percentage of infectivity relative to untreated wild-type TMV. Infectivity data was averaged from eight
independent half-leaf assays. Translational assays were done by charging a rabbit reticulocyte lysate system containing 250 mCi/ml of L-[35S]me-
thionine with 25 mg of virions partially reassembled with excess wild-type or mutant CPs. Translational products were resolved by SDS–PAGE and
the viral 126-kDa protein was quantified using a PhosphoImager Storm 680 (Molecular Dynamics, Sunnyvale, CA). Translational data were averaged
from three independent experiments. Bars represent the percentage of infectivity or translation activity in relation to that of untreated wild-type virions.
Error bars represent standard deviation.
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subunit along with residues F10 and P7 of the laterally
adjacent subunit make up part of a hydrophobic girdle
that encircles each CP layer in the virion. At the virion
mid-radius the side chains of residues I129 and I133 from
one subunit reside in close proximity to residue Y72 of
the laterally adjacent subunit. To determine the effects of
these hydrophobic interactions on TMV disassembly,
disrupting substitutions F10Y, F67A, I129A, and I133L
were added to CP E50Q (Fig. 3). Translational and infec-
tivity assays using purified double mutant CPs indicated
that substitutions F10Y and F67A reduced E50Q’s inhibi-
tion of wild-type TMV by an average of 80 and 54%,
respectively, while substitutions I133L and I129A did not
greatly affect E50Q’s ability to inhibit disassembly (Fig. 2).
Surface-exposed polar residues also act to stabilize
CP–CP aggregation. Polar residues T28 and T42, located
on opposite interfaces, were mutated to I and R, respec-
tively (Fig. 3). These substitutions were designed to dis-
rupt patches of polar residues located along the lateral
intersubunit interface. Substitutions T28I and T42R both
interfered with the ability of E50Q to inhibit disassembly
by more than 52% in translational assays and 43% in
infectivity assays (Fig. 2). This indicates that lateral polar
interactions disrupted by these mutations contribute to
CP E50Q’s inhibition of TMV disassembly.
Within the TMV virion there are several intersubunit
salt bridges that act to stabilize CP–CP interactions. One
such salt bridge is composed of residue D88 from one
FIG. 3. Spatial location of substituted amino acid residues in the structure of the TMV CP. (A) Lateral interactions between three subunits within
the same virion layer, viewed perpendicular to the viral axis. (B) Axial CP–CP and CP–RNA interactions between three subunits located in different
layers of the virion, viewed parallel to the viral axis. (C and D) Three subunits at the virion 59 end and one subunit representing the added CP, viewed
either perpendicular or parallel to the viral axis, respectively. Red, carboxylate residues E50 and D77; orange, substituted residues that greatly affected
E50Q’s ability to inhibit disassembly; green, substituted residues that had less than a 20% effect on E50Q’s ability to inhibit disassembly.
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subunit interacting laterally with residue R122 of an ad-
jacent subunit (Fig. 3). To disrupt this interaction, D88
was mutated to N. This substitution should not affect CP
secondary or tertiary structure but should prevent the
attractive negative–positive interaction between D88 and
R122. Breaking this salt bridge by mutation D88N caused
a 65% reduction in the ability of E50Q to inhibit disas-
sembly (Fig. 2), suggesting that this salt bridge provides
an important CP–CP stabilizing factor.
The inner loop structure is located inside the TMV
virion and contains many of the residues involved in
CP–RNA binding (Figs. 1 and 2). Second-site substitu-
tions made in this CP region were designed to either
disrupt the structure of the loop or directly prevent RNA
binding. Residue P102 is located at the innermost radius
of the loop (Fig. 3). Substitution P102L was created to
disrupt the local secondary structure of this region with
the intent of obstructing the ability of CP to bind RNA
and/or associate with neighboring subunits. However,
substitution P102L produced no significant effect on the
ability of E50Q to inhibit TMV disassembly (Fig. 2). Within
the inner loop, positively charged residues R90 and R92
are directly involved in binding negatively charged RNA
phosphate groups (Fig. 3). Substitutions of R90Q and
R92E were designed to block or repulse these phos-
phate groups and prevent RNA from binding beneath the
added 59 terminal subunits. Substitutions R90Q and
R92E did not, however, affect the ability of E50Q to inhibit
TMV disassembly (Fig. 2). Finally, the side chain of D116
extends upward from the 59 end of the virion and inter-
acts with the RNA from the subunit surface opposite R90
and R92 (Fig. 3). Within the virion, D116 hydrogen bonds
with a ribose hydroxyl group and forms part of a calcium
binding site with an RNA phosphate group. Disruption of
this CP–RNA interaction by substitution D116A resulted
in an average reduction of only 17% in the ability of E50Q
to inhibit disassembly (Fig. 2). This reduction in the ability
of E50Q to inhibit disassembly may be the indirect result
of the D116A mutation altering the position of neighbor-
ing residues, including R122, which forms a salt bridge
with D88 as described above.
Of the seven second-site mutations made to disrupt
intersubunit CP–CP interactions five significantly re-
duced E50Q’s ability to inhibit disassembly by more than
50%. These substitutions were F10Y and F67A, disrupting
the outer radius hydrophobic girdle; T28I and T42R, dis-
rupting mid-radius polar interactions; and D88N, disrupt-
ing an intersubunit salt bridge. Each of these substitu-
tions differ in the way they affect intersubunit interac-
tions. However, all share the ability to disrupt CP–CP
interactions that are oriented toward the virion 59 end
(Fig. 2). Moreover, substitutions I129A and I133L, de-
signed to disrupt interactions oriented away from the
virion 59 end, did not greatly affect E50Q’s inhibition of
disassembly (Fig. 2). This difference in the effects of
second-site substitutions on the ability of E50Q to inhibit
TMV disassembly are a consequence of the polar nature
of disassembly and the presumed mechanism of inhibi-
tion, that is, the exchange of wild-type subunits for mu-
tant subunits at the virion 59 end. Thus, second-site
mutations, F10Y, F67A, T28I, T42R, and D88N, that face
the virion 59 end would interfere directly with the ability of
an added CP subunit to bind to the virion 59 end surface.
In contrast, second-site mutations I129A and I133L,
which face away from the virion 59 end, would not di-
rectly affect the ability of an added CP to bind to the
virion 59 end. However, already bound subunits of either
double mutant I129A or I133L CPs could interfere with
the binding of additional CPs, either laterally or axially
(Fig. 2). This polar effect on disassembly is consistent
with the finding that repulsive carboxylate pair members
that face the virion 59 end, such as E50, have a greater
affect on TMV disassembly than pair members, such as
D77, that face away from the virion 59 end (4). Thus, the
intersubunit interfaces between the exposed 59 end
virion surface and the added terminal CP subunits pro-
vide the stabilizing factors that allow E50Q CP to inhibit
disassembly.
Second-site substitutions P102L, R90Q/R92E, and
D116A were designed to disrupt the RNA binding capa-
bilities of CP E50Q. These mutations failed to signifi-
cantly interfere with E50Q’s inhibition of TMV disassem-
bly. This indicates that the ability of E50Q CP to block
virus disassembly is independent of the stabilizing
forces conferred from binding viral RNA. This also sug-
gests that the addition of E50Q CP to the 59 end of a fully
assembled virion would be sufficient to inhibit disassem-
bly. To test this possibility, wild-type TMV virions (3 mg)
that had not been partially disassembled by exposure to
pH 8.0 buffer were treated with (30 mg) either purified
E50Q CP or, as a control, purified wild-type CP. Wild-type
virions treated in this fashion were subsequently centri-
fuged as before to remove any unbound CP and inocu-
lated onto a TMV local lesion host to test for infectivity
(see Fig. 3 legend for description of infectivity assay).
Results demonstrated that the addition of E50Q CP to
TMV virions that had not been partially disassembled
inhibited infectivity by approximately 67% (averaged from
four independent half-leaf assays) compared to an inhi-
bition of approximately 95% for TMV virions that had
been partially disassembled prior to the addition of E50Q
CP (4). In contrast, the addition of wild-type CP had no
affect on the infectivity of fully assembled TMV virions.
Thus, treatment to partially disassemble TMV virions
prior to the addition of E50Q CP is not required to obtain
significant reductions in virus disassembly. However, the
disassembly treatment does enhance levels of inhibition,
possibly by increasing E50Q CP’s access to terminal
subunit positions at virion 59 end. Taken together, these
findings indicate that E50Q CP does not require binding
to exposed 59 end viral RNA to inhibit disassembly.
The precise 59 end structure of the TMV virion remains
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unknown. TMV virions treated under mild alkaline con-
ditions, similar to those used in this study, have been
shown to release a few CP subunits from the 59 end of
the RNA (18, 19). However, the RNA remains largely
protected from nuclease attack (18). Wilson (18) has
suggested that during assembly the 59 end of the TMV
RNA may be completely covered by a final helical turn of
CP. These terminal CPs would be inherently more unsta-
ble than preceding turns because they would make pro-
tein–protein interactions on only one surface, having
their other surface exposed to the aqueous environment.
This instability would make these terminal subunits more
susceptible to the effects of repulsive carboxylate inter-
actions. The loss of these terminal subunits would ex-
pose RNA-bound CP subunits that could continue to
protect the genome from degradation. Further virion dis-
assembly would require the striping of these CPs from
the RNA 59 end. Factors involved in the removal of these
subunits potentially include destabilization by repulsive
intersubunit carboxylate groups, aberrant CP–RNA inter-
actions due to the structure of the 7-methylguanosine
RNA 59 end cap (21, 22), and weaker CP–RNA interac-
tions in the 59 RNA leader due to a lack of guanine
residues, to which CP binds the most strongly (23, 24).
Together, these factors may lead to sufficient viral RNA
exposure to allow the formation of a translation initiation
complex followed by cotranslational disassembly. The
ability of CP E50Q to inhibit TMV disassembly through
stabilizing interactions that contact the disassembling
virion surface but not the RNA suggest that failure to
release 59 terminal CP subunits, which are not bound to
viral RNA, blocks subsequent TMV disassembly steps.
This finding also indicates that blocking the removal of
terminal CP subunits is an effective strategy for prevent-
ing disassembly.
Altering molecular interactions that stabilize the virion
59 end could provide a novel method to prevent disas-
sembly and improve transgenic strategies for disease
resistance. Results from this study indicate that stabiliz-
ing CP–CP interactions that face the virion 59 end have
the greatest potential to block disassembly. One such
interaction found to significantly contribute to 59 end
stability was the intersubunit salt bridge between resi-
dues D88 and R122. The D88N substitution created to
prevent this interaction should not have disrupted CP
secondary or tertiary structure. However, second-site
mutant D88N did counteract E50Q’s inhibition of disas-
sembly by more than 67%, demonstrating the contribu-
tion of this salt bridge in virion stability. Using this infor-
mation, we attempted to engineer a novel salt bridge into
the CP–CP interface. Substitution E50K was designed to
have two effects on virion stability. First, E50K removes a
repulsive carboxylate group responsible for destabilizing
the virion and second, E50K introduces into the intersub-
unit space a positively charged residue directly opposite
the negatively charged D77 residue. Interestingly, the
E50K substitution resulted in the induction of generalized
necrosis on inoculated plant tissue, an undesirable trait
for use in disease resistance strategies. However, com-
bining E50K with substitution P20L mitigated this necro-
sis (Fig. 4). The mechanism responsible for this varied
host response remains unknown, but may be the result
FIG. 4. Introduction of a novel intersubunit salt bridge. (A) Pheno-
types of CP mutant E50K and P20L/E50K produced on an inoculated
leaf of N. tabacum cv. Xanthi; photograph taken 10 days postinocula-
tion. (B) Effects of added CP E50Q and CP P20L/E50K on the ability of
wild-type TMV to disassemble in translational assays. Translation of
TMV virions with added wild-type, P20L, E50Q, or P20L/E50K CPs. Bars
represent the average 6 standard deviation of the viral 126-kDa trans-
lational product from three independent experiments.
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of different CP–host interactions being either enhanced
or blocked as a result of the structural changes con-
ferred by the different mutations. The P20L/E50K CP was
found to be approximately 20% less effective at inhibiting
TMV disassembly than the E50Q substitution (Fig. 4). The
reduced inhibition of disassembly by CP E50K could be
the result of differences between the side chain volumes
of residues E and K, resulting in a suboptimal salt bridge
with residue D77 of the axially adjacent subunit. How-
ever, the ability of P20L/E50K to inhibit disassembly by
more than 80% in comparison to wild-type CP indicates
the potential of this strategy to engineer novel CPs that
inhibit virus disassembly.
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